NCT04859803

Brief Summary

The rhomboid intercostal block (RIB) can provide good analgesia effects after thoracic surgery . The ultrasound-guided RIB is novel analgesic techniques recently described by Elsharkawy et al. . Additionally, the RISS block anesthetizes the lateral cutaneous branches of the thoracic intercostal nerves and can be used in multiple clinical settings for chest wall and upper abdominal analgesia. However, the analgesic effects of the RISS block after breast surgery have not been analyzed through a randomized-controlled trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Jun 2021

Typical duration for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 26, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 25, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 2, 2023

Completed
Last Updated

December 12, 2023

Status Verified

December 1, 2023

Enrollment Period

2.3 years

First QC Date

April 22, 2021

Last Update Submit

December 6, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • morphine consumption

    Postoperative morphine consumption

    24 hours

Secondary Outcomes (3)

  • recovery time

    1 hour

  • Pain evaluation

    24 hous

  • time to first analgesia

    24 hous

Study Arms (2)

RISS group

ACTIVE COMPARATOR

patients will receive rhomboid intercostal block under ultrasound guidance.

Procedure: Patients will be received rhomboid intercostal block under ultrasound guidance.

Control group

ACTIVE COMPARATOR

Patients will received the conventional intravenous analgesia

Drug: conventional intravenous analgesia

Interventions

Following endotracheal intubation, patients allotted to the RIB group were positioned in the lateral decubitus position with the chest on the operating side lying superiorly. The ipsilateral arm was abducted from the chest to move the scapula laterally. The RIB was performed as described previously \[8\]. A high-frequency (6-12 MHz) linear ultrasound probe (LOGIQ e ultrasonic system, Deutschland GmbH \& Co. KG, Solingen, Germany) was placed medial to the medial border of the scapula in the oblique sagittal plane. The landmarks, i.e., the trapezius muscle, rhomboid muscle, intercostal muscles, pleura, and lung, were identified in the ultrasound. Under aseptic conditions, an 80-mm 21-gauge needle was inserted at the level of T6-7 in the ultrasound view. A single dose of 30 ml 0.25% bupivacaine will be injected in the interfascial plane between the rhomboid major and intercostal muscles. The spread of the local anesthetic solution under the rhomboid muscle was visualized by ultrasonography.

RISS group

Following endotracheal intubation, patients will be received morphine sulfate (0.02 mg/kg) bolus doses were used to preserve MAP and HR within 20% of pre-induction readings

Control group

Eligibility Criteria

Age18 Years - 40 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine, Cairo University.

Cairo, 11451, Egypt

Location

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
double
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 22, 2021

First Posted

April 26, 2021

Study Start

June 1, 2021

Primary Completion

September 25, 2023

Study Completion

November 2, 2023

Last Updated

December 12, 2023

Record last verified: 2023-12

Locations